Tango Therapeutics, Inc. · NASDAQ:TNGX

Dapice Joshua J. reported a 9.70% stake in Tango Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 12, 2025

Dapice Joshua J. reported a 9.70% stake in Tango Therapeutics, Inc., 10,757,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G/A).

Stake
9.70%
Shares
10,757,000
Intent
Passive
What changed
Stake changed
Filed together
28 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.1.60%1,792,415
Farallon Capital Institutional Partners, L.P.2.10%2,301,057
Farallon Capital Institutional Partners II, L.P.0.50%589,896
Farallon Capital Institutional Partners III, L.P.0.40%417,567
Four Crossings Institutional Partners V, L.P.0.50%505,935
Farallon Capital Offshore Investors II, L.P.4.00%4,421,621
Farallon Capital F5 Master I, L.P.0.40%425,421
Farallon Capital (AM) Investors, L.P.0.30%303,088
Farallon Partners, L.L.C.9.30%10,331,579
Farallon Institutional (GP) V, L.L.C.0.50%505,935
Farallon F5 (GP), L.L.C.0.40%425,421
Dapice Joshua J.9.70%10,757,000
Dreyfuss, Philip D.9.70%10,757,000
Dunn Hannah E.9.70%10,757,000
Fried, Richard B9.70%10,757,000
Gehani, Varun N.9.70%10,757,000
Giauque, Nicolas9.70%10,757,000
Kim, David T.9.70%10,757,000
Linn, Michael G.9.70%10,757,000
Luo Patrick (Cheng)9.70%10,757,000
Patel, Rajiv A.9.70%10,757,000
Roberts, Jr., Thomas G.9.70%10,757,000
Saito Edric C.9.70%10,757,000
Seybold, William9.70%10,757,000
Short Daniel S.9.70%10,757,000
Spokes, Andrew J. M.9.70%10,757,000
Warren, John R.9.70%10,757,000
Wehrly, Mark C.9.70%10,757,000

Source

View original at SEC

Related